M. Le, Modulations envisagées sur l'adénine avant réaction avec, Schéma, vol.4, p.80

T. Ai, S. Bompadre, Y. Sohma, X. Wang, M. Li et al., Direct effects of 9-anthracene compounds on cystic fibrosis transmembrane conductance regulator gating, Pfl???gers Archiv - European Journal of Physiology, vol.274, issue.1, 2004.
DOI : 10.1007/s00424-004-1317-y

T. Ai, S. Bompadre, X. Wang, S. Hu, M. Li et al., Capsaicin Potentiates Wild-Type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Chloride-Channel Currents, Molecular Pharmacology, vol.65, issue.6, p.1415, 2004.
DOI : 10.1124/mol.65.6.1415
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283138/pdf

K. Alarcon, M. Demeunynck, J. Lhomme, D. Carrez, and A. Croisy, Diaminopurine-acridine heterodimers for specific recognition of abasic site containing DNA, Influence on the biological activity of the position of the linker on the purine ring, 1855.

M. Amaral and K. Kunzelmann, Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis, Trends in Pharmacological Sciences, vol.28, issue.7, p.334, 2007.
DOI : 10.1016/j.tips.2007.05.004

A. Bachmann, U. Russ, and U. Quast, Potent inhibition of the CFTR chloride channel by suramin, Naunyn-Schmiedebergs Archives of Pharmacology 360, p.473, 1999.

F. Becq, On the Discovery and Development of CFTR Chloride Channel Activators, Current Pharmaceutical Design, vol.12, issue.4, p.471, 2006.
DOI : 10.2174/138161206775474459

C. Figarella, B. Verrier, M. Gola, and J. Vierfond, Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel, Journal of Biological Chemistry, vol.274, p.27415, 1999.

E. J. Sorscher, Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line, Nature Medicine, vol.3, 1280.

A. Berger, C. Randak, L. Ostedgaard, P. Karp, D. Vermeer et al., Curcumin Stimulates Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channel Activity, Journal of Biological Chemistry, vol.280, issue.7, p.5221, 2005.
DOI : 10.1074/jbc.M412972200

J. Best and P. Quinton, Salivary secretion assay for drug efficacy for cystic fibrosis in mice, Experimental Physiology, vol.286, issue.Suppl. 1, 2005.
DOI : 10.1152/ajpcell.00397.2003

M. Brownlee, Biochemistry and molecular cell biology of diabetic complications, Nature, vol.414, issue.6865, 2001.
DOI : 10.1038/414813a

J. Burke and A. Mogg, by the aminoglycoside anthiotics G???418 and paromomycin, Nucleic Acids Research, vol.13, issue.17, p.6265, 1985.
DOI : 10.1093/nar/13.17.6265

E. Caci, C. Folli, O. Zegarra-moran, T. Ma, M. Springsteel et al., CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds, American Journal of Physiology - Lung Cellular and Molecular Physiology, vol.285, issue.1, p.180, 2003.
DOI : 10.1152/ajplung.00351.2002

Z. Cai, H. Li, T. Scott-ward, and D. N. Sheppard, Pharmacology of the CFTR Cl- Channel, 2003.

Z. Cai, T. Scott-ward, H. Li, A. Schmidt, and D. Sheppard, Strategies to investigate the mechanism of action of CFTR modulators, Journal of Cystic Fibrosis, vol.3, p.141, 2004.
DOI : 10.1016/j.jcf.2004.05.030

J. Clancy, Z. Bobok, F. Ruiz, C. King, J. Jones et al., Evidence that Systemic Gentamicin Suppresses Premature Stop Mutations in Patients with Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.163, issue.7, p.1683, 2001.
DOI : 10.1164/ajrccm.163.7.2004001

J. Cuppoletti, K. Tewari, A. Sherry, E. Kupert, and D. Malinowska, ClC-2Cl(-) channels in human lung epithelia: activation by arachidonic acid, amidation, and acidactivated omeprazole, American Journal of Physiology-Cell Physiology, vol.281, p.46, 2001.

P. Davis, M. Drumm, A. Decarvalho, C. Ndi, A. Tsopmo et al., Some like it hot: curcumin and CFTR, Trends in Molecular Medicine 10, 473 A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR Delta F508, Molecular Medicine, vol.8, p.75, 2002.

G. Denning, M. Anderson, J. Amara, J. Marshall, A. Smith et al., Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive, Nature, vol.358, issue.6389, p.761, 1992.
DOI : 10.1038/358761a0

I. Devillers, G. Dive, C. Tollenaere, B. Falmagne, B. De-wergifosse et al., Imidazolopyrazinones as potential antioxidants, Bioorganic & Medicinal Chemistry Letters, vol.11, issue.17, 2001.
DOI : 10.1016/S0960-894X(01)00445-0

T. Diena, R. Melani, E. Caci, N. Pedemonte, E. Sondo et al., Block of CFTR-dependent chloride currents by inhibitors of multidrug resistanceassociated proteins, European Journal of Pharmacology, vol.560, issue.127, 2007.

M. Field, Intestinal ion transport and the pathophysiology of diarrhea, Journal of Clinical Investigation, vol.111, issue.7, p.931, 2003.
DOI : 10.1172/JCI18326DS1

H. Fischer, T. Machen, J. Widdicombe, T. Carlson, S. King et al., A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells, Journal of Ethnopharmacology, vol.93, issue.2-3, p.351, 2004.
DOI : 10.1016/j.jep.2004.04.005

B. Sarkadi, D. Mcmaster, R. French, J. Pohl, J. Kubanek et al., Statedependent inhibition of cystic fibrosis transmembrane conductance regulator chloride channels by a novel peptide toxin, Journal of Biological Chemistry, vol.282, p.37545, 2007.

S. Gabriel, K. Brigman, B. Koller, R. Boucher, and M. Stutts, Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model, Science, vol.266, issue.5182, 1994.
DOI : 10.1126/science.7524148

S. Gabriel, S. Davenport, R. Steagall, V. Vimal, T. Carlson et al., A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion, American Journal of Physiology-Gastrointestinal and Liver Physiology, vol.276, p.58, 1999.

E. Garnier, J. Guillard, E. Pasquinet, F. Suzenet, D. Poullain et al., Highly Diastereoselective Synthesis of C(6)-Functionalized Dihydroimidazotriazines, Organic Letters, vol.5, issue.24, p.4595, 2003.
DOI : 10.1021/ol035743e

K. Ghosh, T. Sen, and R. Froehlich, Adenine-based receptor for dicarboxylic acids, Tetrahedron Letters, vol.48, issue.39, p.7022, 2007.
DOI : 10.1016/j.tetlet.2007.07.110

M. Ghosh, D. Talukdar, S. Ghosh, N. Bhattacharyya, M. Ray et al., In vivo assessment of toxicity and pharmacokinetics of methylglyoxal, Toxicology and Applied Pharmacology, vol.212, issue.1, p.45, 2006.
DOI : 10.1016/j.taap.2005.07.003

U. Gi and W. Baltes, Model Reactions on Roast Aroma Formation. 15. Investigations on the Formation of Pyrido[3,4-d]imidazoles during the Maillard Reactions, Model Reactions on Roast Aroma Formation. 15. Investigations on the Formation of Pyrido[3,4-d]imidazoles during the Maillard Reactions, p.2226, 1995.
DOI : 10.1021/jf00056a048

X. Gong, P. Linsdell, K. Cheung, G. Leung, and P. Wong, Indazole inhibition of cystic fibrosis transmembrane conductance regulator Cl-channels in rat epididymal epithelial cells, Biology of Reproduction, vol.67, 1888.

J. Hanrahan and M. Wioland, Revisiting Cystic Fibrosis Transmembrane Conductance Regulator Structure and Function, Proceedings of the American Thoracic Society, vol.1, issue.1, p.17, 2004.
DOI : 10.1513/pats.2306009
URL : http://doi.org/10.1513/pats.2306009

H. Yang, Natural compound curcumin corrects the gating defect of G551Dmutant cystic fibrosis transmembrane conductance regulator, Chemical Research in Chinese Universities, vol.24, p.92, 2008.

C. He, L. Zhao, Y. Liu, L. Xu, D. Shang et al., A class of high-affinity bicyclooctane G551D-CFTR activators identified by high throughput screening, Chemical Research in Chinese Universities, vol.20, p.743, 2004.

C. Hogenauer, C. Ana, J. Porter, M. Millard, A. Gelfand et al., Active Intestinal Chloride Secretion in Human Carriers of Cystic Fibrosis Mutations: An Evaluation of the Hypothesis That Heterozygotes Have Subnormal Active Intestinal Chloride Secretion, The American Journal of Human Genetics, vol.67, issue.6, p.1422, 2000.
DOI : 10.1086/316911

A. Holy, Synthesis of new mono- and disubstituted hydroxyalkyl and aminoalkyl derivatives of heterocyclic bases, Collection of Czechoslovak Chemical Communications, vol.43, issue.12, p.3444, 1978.
DOI : 10.1135/cccc19783444

Y. Ito, M. Aoyama, N. Yamada, Y. Mizuno, H. Kume et al., [(Dihydroindenyl)oxy]alkaonic acid inhibits the cystic fibrosis transmembrane conductance regulator, European Journal of Pharmacology, vol.426, issue.3, p.175, 2001.
DOI : 10.1016/S0014-2999(01)01106-2

H. Jang, R. Huddleston, and M. J. Krische, A New Catalytic C???C Bond-Forming Hydrogenation: Reductive Coupling of Dienes and Glyoxals under Catalytic Hydrogenation Conditions, Angewandte Chemie International Edition, vol.42, issue.34, p.4074, 2003.
DOI : 10.1002/anie.200351986

H. Jang, R. Huddleston, and M. J. Krische, Hydrogen-Mediated C???C Bond Formation:?? Catalytic Regio- and Stereoselective Reductive Condensation of ??-Keto Aldehydes and 1,3-Enynes, Journal of the American Chemical Society, vol.126, issue.14, p.4664, 2004.
DOI : 10.1021/ja0316566

L. Jin, X. Liu, Y. Sun, S. Lin, N. Zhou et al., Activation of CFTR-mediated Cl??? Transport by Magnolin, Chinese Universities 24, 2008.
DOI : 10.1016/S1005-9040(08)60038-0

M. P. Kalapos, Methylglyoxal in living organisms, Toxicology Letters, vol.110, issue.3, p.145, 1999.
DOI : 10.1016/S0378-4274(99)00160-5

E. Kerem, Mutation specific therapy in CF, Paediatric Respiratory Reviews, vol.7, p.166, 2006.
DOI : 10.1016/j.prrv.2006.04.213

A. Konstas, J. Koch, S. Tucker, and C. Korbmacher, Cystic Fibrosis Transmembrane Conductance Regulator-dependent Up-regulation of Kir1.1 (ROMK) Renal K+ Channels by the Epithelial Sodium Channel, Journal of Biological Chemistry, vol.277, issue.28, p.25377, 2002.
DOI : 10.1074/jbc.M201925200

Y. Babu and P. Chand, An efficient synthesis of acyclic N-7-and N-9-adenine nucleosides via alkylation with secondary carbon electrophiles to introduce versatile functional groups at the C-1 position of acyclic moiety, Nucleosides Nucleotides & Nucleic Acids, vol.25, issue.121, 2006.

N. K. Kuroda and S. Akiyama, Chemiluminescence method for the determination of adenine after reaction with phenylglyoxal, Analytica Chimica Acta, vol.278, issue.2, p.275, 1993.
DOI : 10.1016/0003-2670(93)85110-6

A. Laayoun, Nucleoside modifies et lesions de l'ADN -mise au point d'une nouvelle methode de synthese d'oligonucleotides a site abasique, 1992.

A. Laayoun, J. Decout, and J. Lhomme, Hydrolysis of 2???-deoxypurine nucleosides. The effect of substitution at the C-8 position, Tetrahedron Letters, vol.35, issue.28, p.4989, 1994.
DOI : 10.1016/S0040-4039(00)73300-4

J. Lallemand, V. Stoven, J. Annereau, J. Boucher, S. Blanquet et al., Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis?, The Lancet, vol.350, issue.9079, p.711, 1997.
DOI : 10.1016/S0140-6736(05)63510-6
URL : https://hal.archives-ouvertes.fr/hal-00772899

R. Volpini, New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile, Purinergic Signalling, vol.3, p.339, 2007.

D. Clercq and E. , Synthesis and anti-HIV activity of new modified 1,2,3-triazole acyclonucleosides, Nucleosides, Nucleotides & Nucleic Acids, vol.20, 1949.

Y. Li, M. Cohenford, U. Dutta, and J. A. Dain, The structural modification of DNA nucleosides by nonenzymatic glycation: an in vitro study based on the reactions of glyoxal and methylglyoxal with 2???-deoxyguanosine, Analytical and Bioanalytical Chemistry, vol.386, issue.2, p.679, 2008.
DOI : 10.1007/s00216-007-1682-4

P. Linsdell, Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel currents by arachidonic acid, Canadian Journal of Physiology and Pharmacology, vol.78, issue.6, p.490, 2000.
DOI : 10.1139/y00-014

K. Linton, Structure and Function of ABC Transporters, Physiology, vol.22, issue.2, 2007.
DOI : 10.1152/physiol.00046.2006

J. Liu, W. Na, W. Xin, L. Liu, B. Yu et al., Natural compound 20(S)protopanaxadiol activates cystic fibrosis transmembrane conductance regulator chloride channel, Chemical Journal of Chinese Universities-Chinese, vol.29, p.731, 2008.

L. Liu, M. Chen, and K. Cai, Oxidation of a-methyl or a-methylene groups in carbonyl compounds with ammonium chlorochromate, Chinese Chemical Letters, vol.3, p.585, 1992.

G. Loussouarn, S. Demolombe, R. Mohammadpanah, D. Escande, and I. Baro, Expression of CFTR controls cAMP-dependent activation of epithelial K+ currents, American Journal of Physiology-Cell Physiology, vol.40, p.1565, 1996.

T. Ma, J. Thiagarajah, H. Yang, N. Sonawane, C. Folli et al., Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin???induced intestinal fluid secretion, Journal of Clinical Investigation, vol.110, issue.11, p.1651, 2002.
DOI : 10.1172/JCI0216112

T. Ma, L. Vetrivel, H. Yang, N. Pedemonte, O. Zegarra-moran et al., High-affinity Activators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Conductance Identified by High-throughput Screening, Journal of Biological Chemistry, vol.277, issue.40, p.37235, 2002.
DOI : 10.1074/jbc.M205932200

M. Mall, M. Bleich, R. Greger, R. Schreiber, and K. Kunzelmann, The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways., Journal of Clinical Investigation, vol.102, issue.1, p.15, 1998.
DOI : 10.1172/JCI2729

B. Marcet, F. Becq, C. Norez, P. Delmas, and B. Verrier, General anesthetic octanol and related compounds activate wild-type and delF508 cystic fibrosis chloride channels, British Journal of Pharmacology, vol.600, issue.6, p.905, 2004.
DOI : 10.1038/sj.bjp.0705684
URL : https://hal.archives-ouvertes.fr/hal-00143529

G. Morgant, F. Becq, J. Vierfond, and Y. Mettey, Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels, Journal of Medicinal Chemistry, vol.47, p.962, 2004.

T. Maruyama, S. Kozai, and F. Sasaki, Method for the Synthesis of Uric Acid Derivatives, Nucleosides, Nucleotides and Nucleic Acids, vol.195, issue.7, 1193.
DOI : 10.1039/jr9550000211

S. Meade, A. Miller, and J. A. Gerrard, The role of dicarbonyl compounds in nonenzymatic crosslinking: a structure-activity study, Bioorg Med Chem, vol.11, issue.853, 2003.

J. Mornon, P. Lehn, and I. Callebaut, Atomic model of human cystic fibrosis transmembrane conductance regulator: Membrane-spanning domains and coupling interfaces, Cellular and Molecular Life Sciences, vol.65, issue.16, p.2594, 2008.
DOI : 10.1007/s00018-008-8249-1
URL : https://hal.archives-ouvertes.fr/hal-00288535

T. Kere, M. Anvret, N. Dahl, and L. Kadasi, The Origin of the Major Cystic-Fibrosis Mutation (Delta-F508) in European Populations, Nature Genetics, vol.7, p.169, 1994.

C. Muanprasat, S. Kaewmokul, and V. Chatsudthipong, Identification of New Small Molecule Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Protein: In Vitro and in Vivo Studies, Biological & Pharmaceutical Bulletin, vol.30, issue.3, p.502, 2007.
DOI : 10.1248/bpb.30.502

C. Muanprasat, N. Sonawane, D. Salinas, A. Taddei, L. Galietta et al., Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors, The Journal of General Physiology, vol.95, issue.2, p.125, 2004.
DOI : 10.1085/jgp.20028685

I. Nemet, D. Vikic-topic, and L. Varga-defterdarovic, Spectroscopic studies of methylglyoxal in water and dimethylsulfoxide, Bioorganic Chemistry, vol.32, issue.6, p.560, 2004.
DOI : 10.1016/j.bioorg.2004.05.008

M. Nielsen, A. Thomsen, E. Clo, F. Kirpekar, and K. Gothelf, Synthesis of Linear and Tripoidal Oligo(phenyleneethynylene)-Based Building Blocks for Application in Modular DNA-Programmed Assembly, Journal of Organic Chemistry, vol.69, 2004.

H. Pollard, J. Yankaskas, and B. Kerem, Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation, 1071.

S. Noel, C. Faveau, C. Norez, C. Rogier, Y. Mettey et al., Discovery of Pyrrolo[2,3-b]pyrazines Derivatives as Submicromolar Affinity Activators of Wild Type, G551D, and F508del Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels, Journal of Pharmacology and Experimental Therapeutics, vol.319, issue.1, p.349, 2006.
DOI : 10.1124/jpet.106.104521

C. Norez, S. Noel, M. Wilke, M. Bijvelds, H. Jorna et al., Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alphaglucosidase inhibitor miglustat, Febs Letters, vol.580, 2006.

Y. Ohba, M. Sakata, and K. Zaitsu, Chemiluminescence Derivatization of Methylglyoxal Using 2-Aminonicotinic Acid., CHEMICAL & PHARMACEUTICAL BULLETIN, vol.48, issue.8, 1236.
DOI : 10.1248/cpb.48.1236

T. Oya, N. Hattori, Y. Mizuno, S. Miyata, S. Maeda et al., Methylglyoxal Modification of Protein: CHEMICAL AND IMMUNOCHEMICAL CHARACTERIZATION OF METHYLGLYOXAL-ARGININE ADDUCTS, Journal of Biological Chemistry, vol.274, issue.26, p.18492, 1999.
DOI : 10.1074/jbc.274.26.18492

P. Pariwat, S. Homvisasevongsa, C. Muanprasat, and V. Chatsudthipong, A Natural Plant-Derived Dihydroisosteviol Prevents Cholera Toxin-Induced Intestinal Fluid Secretion, Journal of Pharmacology and Experimental Therapeutics, vol.324, issue.2, p.798, 2008.
DOI : 10.1124/jpet.107.129288

N. Pedemonte, D. Boido, O. Moran, M. Giampieri, M. Mazzei et al., Structure-Activity Relationship of 1,4-Dihydropyridines as Potentiators of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel, Molecular Pharmacology, vol.72, issue.1, 0197.
DOI : 10.1124/mol.107.034702

N. Pedemonte, T. Diena, E. Caci, E. Nieddu, M. Mazzei et al., Antihypertensive 1,4-dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations, Molecular Pharmacology, vol.68, p.1736, 2005.

N. Pedemonte, N. Sonawane, A. Taddei, J. Hu, O. Zegarra-moran et al., Phenylglycine and Sulfonamide Correctors of Defective ??F508 and G551D Cystic Fibrosis Transmembrane Conductance Regulator Chloride-Channel Gating, Molecular Pharmacology, vol.67, issue.5, p.1797, 2005.
DOI : 10.1124/mol.105.010959

V. Petrov, A. Ozerov, M. Novikov, C. Pannecouque, J. Balzarini et al., aryloxyethyl) derivatives of adenine -a new class of non-nucleosidic antiviral agents, Chemistry of Heterocyclic Compounds, issue.92, 2003.

E. Poolman and A. Galvani, Evaluating candidate agents of selective pressure for cystic fibrosis, Journal of The Royal Society Interface, vol.4, issue.12, p.91, 2007.
DOI : 10.1098/rsif.2006.0154

F. Price, New: liquid-process sodium silicate, Chem. Eng, vol.69, p.76, 1962.

D. Ranganathan and R. Rathi, Urea cycle: chemical simulation of arginine biosynthesis, The Journal of Organic Chemistry, vol.55, issue.8, p.2351, 1990.
DOI : 10.1021/jo00295a022

M. Rasmussen and J. Hope, Heterocyclic ambident nucleophiles. III. The alkylation of sodium adenide, Australian Journal of Chemistry, vol.35, issue.3, p.525, 1982.
DOI : 10.1071/CH9820525

J. Riordan, ASSEMBLY OF FUNCTIONAL CFTR CHLORIDE CHANNELS, Annual Review of Physiology, vol.67, issue.1, p.701, 2005.
DOI : 10.1146/annurev.physiol.67.032003.154107

J. Riordan, CFTR Function and Prospects for Therapy, Annual Review of Biochemistry, vol.77, issue.1, p.701, 2008.
DOI : 10.1146/annurev.biochem.75.103004.142532

J. Riordan, J. Rommens, B. Kerem, N. Alon, R. Rozmahel et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, vol.245, 1066.

M. Roussey, La Mucoviscidose, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00690789

C. Routaboul, Nouvelle réaction du méthylglyoxal avec des bases nucléiques et des composés apparentés. Accès à de nouvelles familles d'hétérocycles, 2003.

C. Routaboul, L. Dumas, I. Gautier-luneau, J. Vergne, M. Maurel et al., New stereoselective reaction of methylglyoxal with 2-aminopyridine and adenine derivatives: Formation of imino acid-nucleic base derivatives in water under mild conditions, Chemical Communications, 1114.

C. Gauthier, B. Frederic, and J. Decout, Discovery of alpha-aminoazaheterocyclemethylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels, Journal of Pharmacology and Experimental Therapeutics, vol.322, 1023.

R. Rowntree and A. Harris, The Phenotypic Consequences of CFTR Mutations, Annals of Human Genetics, vol.10, issue.5, p.471, 2003.
DOI : 10.1146/annurev.genet.29.1.777

R. Sammelson, T. Ma, L. Galietta, A. Verkman, and M. Kurth, benzyloxyphenyl)isoxazoles and isoxazolines: Synthesis and evaluation as CFTR activators, Bioorganic & Medicinal Chemistry Letters, vol.13, issue.32, 2003.

B. Schultz, C. J. Venglarik, R. Bridges, and R. Frizzell, Regulation of CFTR Cl- channel gating by ADP and ATP analogues, Regulation of Cftr Cl-Channel Gating by Adp and Atp Analogs, p.329, 1995.
DOI : 10.1085/jgp.105.3.329

E. Schwiebert, D. J. Benos, M. Egan, M. Stutts, and W. Guggino, CFTR is a conductance regulator as well as a chloride channel, Physiol Rev, vol.79, p.145, 1999.

I. Sermet-gaudelus, V. Stoven, J. Annereau, V. Witko-sarsat, P. Reinert et al., Interest of Colchicine for the Treatment of Cystic Fibrosis Patients. Preliminary Report, Mediators of Inflammation, vol.8, issue.1, p.13, 1999.
DOI : 10.1080/09629359990667

D. Sheppard, CFTR channel pharmacology: Novel pore blockers identified by highthroughput screening, Journal of General Physiology, vol.124, issue.109, 2004.
DOI : 10.1085/jgp.200409135
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2229622

D. Sheppard and M. Welsh, Structure and function of the CFTR chloride channel, Physiol Rev, vol.79, p.23, 1999.

A. Singh, D. Devor, A. Gerlach, M. Gondor, J. Pilewski et al., Stimulation of Cl-secretion by chlorzoxazone, Journal of Pharmacology and Experimental Therapeutics, vol.292, p.778, 2000.

S. Rad, M. Khalafi-nezhad, A. Behrouz, S. Faghihi, M. Zare et al., One-pot synthesis of N-alkyl purine and pyrimidine derivatives from alcohols using TsIm: a rapid entry into carboacyclic nucleoside synthesis, Tetrahedron, vol.64, p.1778, 2008.

N. Sonawane, J. Hu, C. Muanprasat, and A. Verkman, Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid loss in cholera, The FASEB Journal, vol.19, issue.130, 2005.
DOI : 10.1096/fj.05-4818fje

N. Sonawane, D. Zhao, O. Zegarra-moran, L. Galietta, and A. Verkman, Lectin Conjugates as Potent, Nonabsorbable CFTR Inhibitors for Reducing Intestinal Fluid Secretion in Cholera, Gastroenterology, vol.132, issue.4, 1234.
DOI : 10.1053/j.gastro.2007.02.018

A. Szkotak, M. Murthy, L. Macvinish, M. Duszyk, and A. Cuthbert, ]isoquinoline (CBIQ) activates CFTR chloride channels and KCNN4 potassium channels in Calu-3 human airway epithelial cells, British Journal of Pharmacology, vol.278, issue.3, p.531, 2004.
DOI : 10.1038/sj.bjp.0705846

J. Thiagarajah and A. Verkman, New drug targets for cholera therapy, Trends in Pharmacological Sciences, vol.26, issue.4, p.172, 2005.
DOI : 10.1016/j.tips.2005.02.003

J. Thibon, L. Latxague, and G. Deleris, Synthesis of Silicon Analogues of Acyclonucleotides Incorporable in Oligonucleotide Solid-Phase Synthesis, The Journal of Organic Chemistry, vol.62, issue.14, p.4635, 1997.
DOI : 10.1021/jo962165p

P. J. Thornalley, Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy, General Pharmacology: The Vascular System, vol.27, issue.4, p.565, 1996.
DOI : 10.1016/0306-3623(95)02054-3

M. Van-der-deen, E. Vries, W. Timens, R. Scheper, H. Timmer-bosscha et al., ATP-binding cassette (ABC) transporters in normal and pathological lung, Respiratory Research, vol.508, issue.1, 2005.
DOI : 10.1186/1465-9921-6-59

K. Vancompernolle, Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methyl glyoxal-derived AGE, Proceedings of the National Academy of Sciences of the United States of America 99, p.949, 2002.

J. Rader, F. Chambers, I. Miller, M. Grootenhuis, P. Liu et al., Preparation of substituted pyrazoles as modulators of ATP-binding cassette transporters, Application: WOVertex Pharmaceuticals Incorporated, vol.174, 2004.

A. Vankeerberghen, H. Cuppens, and J. Cassiman, The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions, Journal of Cystic Fibrosis, vol.1, issue.1, p.13, 2002.
DOI : 10.1016/S1569-1993(01)00003-0

C. J. Venglarik, R. Bridges, and R. Frizzell, A Simple Assay for Agonist-Regulated Cl and K-Conductances in Salt-Secreting Epithelial-Cells, American Journal of Physiology, vol.259, p.358, 1990.

R. Verhe, D. Courtheyn, N. De-kimpe, L. De-buyck, and N. Schamp, Preparation of 1,1-Dialkoxy-2-alkanones, Synthesis, vol.1982, issue.08, 1982.
DOI : 10.1055/s-1982-29895

W. Wang, K. Bernard, G. Li, and K. Kirk, Curcumin Opens Cystic Fibrosis Transmembrane Conductance Regulator Channels by a Novel Mechanism That Requires neither ATP Binding nor Dimerization of the Nucleotide-binding Domains, Journal of Biological Chemistry, vol.282, issue.7, p.4533, 2007.
DOI : 10.1074/jbc.M609942200

W. Wang, G. Li, J. Clancy, and K. Kirk, Activating Cystic Fibrosis Transmembrane Conductance Regulator Channels with Pore Blocker Analogs, Journal of Biological Chemistry, vol.280, issue.25, p.23622, 2005.
DOI : 10.1074/jbc.M503118200

M. Welsh and A. Smith, Molecular Mechanisms of Cftr Chloride Channel Dysfunction in Cystic-Fibrosis, Cell 73, 1251.

M. Wilschanski, Y. Yahav, Y. Yaacov, H. Blau, L. Bentur et al., Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations, Bebok Z; Shushi L; Kerem B; Kerem E New England Journal of Medicine, vol.349, 1433.

P. Wyde, M. Ambrose, L. Meyerson, and B. Gilbert, The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats, Antiviral Research, vol.20, issue.2, p.145, 1993.
DOI : 10.1016/0166-3542(93)90004-3

H. Xu, W. Shen, Y. Tang, J. Shen, W. Shan et al., Preparation for 2-oxobutanal from 1,2- butanediol, Application: CN, vol.6, p.pp, 2005.

H. Yang, A. Shelat, R. Guy, V. Gopinath, T. Ma et al., Nanomolar Affinity Small Molecule Correctors of Defective ??F508-CFTR Chloride Channel Gating, Journal of Biological Chemistry, vol.278, issue.37, p.35079, 2003.
DOI : 10.1074/jbc.M303098200

M. Yang, P. Kuo, A. Damu, R. Chang, W. Chiou et al., A versatile route to the synthesis of 1-substituted ??-carbolines by a single step Pictet???Spengler cyclization, Tetrahedron, vol.62, issue.47, p.10900, 2006.
DOI : 10.1016/j.tet.2006.08.081

R. Young, M. Jones, K. Milliner, K. Rana, and J. Ward, Purine derivatives as competitive inhibitors of human erythrocyte membrane phosphatidylinositol 4-kinase, Journal of Medicinal Chemistry, vol.33, issue.8, 1990.
DOI : 10.1021/jm00170a005

S. Zav-'yalov and G. Ezhova, Synthesis of a-dicarbonyl compounds from N-acyl-a-amino ketones, 1044.

P. Zeitlin, Novel pharmacologic therapies for cystic fibrosis, Journal of Clinical Investigation, vol.103, issue.4, p.447, 1999.
DOI : 10.1172/JCI6346